AngioDynamics: A MedTech Powerhouse Emerging From Legacy Overhaul

Core Insights - AngioDynamics (ANGO) is undergoing a multi-year transformation and is nearing an inflection point in its business strategy [1] - The company has divested its legacy assets and resolved litigation issues, allowing it to focus on sales growth [1] Company Developments - AngioDynamics has successfully divested from legacy assets, which is a significant step in its transformation process [1] - The resolution of litigation has cleared obstacles for the company, enabling a more concentrated effort on expanding its sales [1] Growth Potential - With the divestiture and litigation resolved, AngioDynamics is positioned to capitalize on growth opportunities in the market [1]